Literature DB >> 17193825

Occurrence of other malignancies in patients with gastrointestinal stromal tumors.

Abbas Agaimy1, Peter H Wünsch, Leslie H Sobin, Jerzy Lasota, Markku Miettinen.   

Abstract

Almost one-third of gastrointestinal stromal tumors (GISTs) are discovered incidentally during investigative or therapeutic procedures for unrelated diseases. In this regard, GISTs may coexist with different types of cancer, either synchronously or metachronously. The frequency of this association and the spectrum of neoplasms involved have not been sufficiently analyzed. We conducted a review of the literature and our own records for cases with sporadic GISTs and other malignancies, with emphasis on solid tumors. Neurofibromatosis 1 and Carney triad-associated tumors were excluded. Based on these data, there were 518 cancers in 486 GIST patients among 4813 cases with informative data. The overall frequency of second tumors in different series varied from 4.5% to 33% (mean, 13%). A total of 29 patients had multiple malignancies. GISTs of gastric location were most commonly involved with other neoplasms, reflecting their overall high frequency (60%) of all GISTs. The major types of GIST-associated cancers were gastrointestinal carcinomas (n=228; 47%), lymphoma/leukemia, (n=36; 7%), and carcinomas of prostate (n=43; 9%), breast (n=34; 7%), kidney (n=27; 6%), lung (n=26; 5%), female genital tract (n=25; 5%), and carcinoid tumors (n=13; 3%). Other cancers included soft tissue and bone sarcomas (n=15; 3%), malignant melanoma (n=12; 2%), and seminoma (n=6; 1%). Occurrence of collision tumors and metastases of carcinoma or sarcoma into a GIST (the latter noted in 4 cases) can be challenging diagnostic problems. The potential nonrandom association and causal relationship between GIST and other neoplasms remain to be investigated.

Entities:  

Mesh:

Year:  2006        PMID: 17193825     DOI: 10.1053/j.semdp.2006.09.004

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  88 in total

1.  Significance of Primary Malignant Tumors on the Outcome of Patients With Resected Gastrointestinal Stromal Tumors.

Authors:  Shuzo Kohno; Hiroaki Aoki; Masaichi Ogawa; Kazuhiko Yoshida; Katsuhiko Yanaga
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  [Bony space-occupying lesion at the lumbosacral junction with malignant primary disease].

Authors:  K Lutz; F L Giesel; C M Zechmann
Journal:  Radiologe       Date:  2009-02       Impact factor: 0.635

3.  Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate.

Authors:  Jacopo Giuliani; Andrea Bonetti
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

4.  Criminal or bystander: imatinib and second primary malignancy in GIST patients.

Authors:  Tatsuo Kanda
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

5.  Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study.

Authors:  James D Murphy; Grace L Ma; Joel M Baumgartner; Lisa Madlensky; Adam M Burgoyne; Chih-Min Tang; Maria Elena Martinez; Jason K Sicklick
Journal:  Cancer       Date:  2015-04-30       Impact factor: 6.860

Review 6.  Gastrointestinal stromal tumors.

Authors:  Maureen J O'Sullivan
Journal:  Pediatr Surg Int       Date:  2009-10       Impact factor: 1.827

7.  p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome.

Authors:  Michael Schmieder; Sebastian Wolf; Bettina Danner; Susanne Stoehr; Markus S Juchems; Peter Wuerl; Doris Henne-Bruns; Uwe Knippschild; Cornelia Hasel; Klaus Kramer
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

8.  Perivascular epithelioid cell tumor of the liver coexisting with a gastrointestinal stromal tumor.

Authors:  Carlos Eduardo Paiva; Francisco Alves Moraes Neto; Abbas Agaimy; Maria Aparecida Custodio Domingues; Silvia Regina Rogatto
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

9.  BRCA 1/2 gene mutation and gastrointestinal stromal tumours: a potential association.

Authors:  Julie Waisbren; Regina Uthe; Kalliopi Siziopikou; Virginia Kaklamani
Journal:  BMJ Case Rep       Date:  2015-07-06

10.  Gastric carcinoid tumor in a patient with a past history of gastrointestinal stromal tumor of the stomach.

Authors:  Chien-Yuan Hung; Ming-Jen Chen; Shou-Chuan Shih; Tsang-Pai Liu; Yu-Jan Chan; Tsang-En Wang; Wen-Hsiung Chang
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.